TRPM6 Activators
Chemical activators of the Transient receptor potential cation channel subfamily M member, or TRPM channels, encompass a broad class of compounds that can modulate the activity of these ion channels. Their mode of action can be direct, through binding to the ion channel itself, or indirect, by influencing signaling pathways that regulate channel activity. Direct activators, such as magnesium chloride, zinc chloride, 1-oleoyl-rac-glycerol, and spermine, interact with TRPM channels at various sites. For instance, magnesium and zinc ions can bind to the ion channel, promoting its transport function. Similarly, the lipid compound 1-oleoyl-rac-glycerol interacts with lipid-interaction domains on the protein, thus enhancing its activity. Spermine also binds to TRPM channels, resulting in the enhancement of their ion channel activity and the associated transport function.
On the other hand, indirect activators exert their influence by modulating cellular signaling pathways that regulate TRPM channel activity. Compounds like forskolin and 3-isobutyl-1-methylxanthine (IBMX) increase intracellular cAMP levels, leading to activation of protein kinase A (PKA). PKA can then phosphorylate TRPM channels, stimulating their activity. Phorbol 12-myristate 13-acetate (PMA) also falls into this category, activating the protein kinase C (PKC) pathway, which subsequently phosphorylates and enhances TRPM channel activity. Certain activators, such as nifedipine and tetrabromocinnamic acid (TBCA), reduce inhibitory mechanisms on TRPM channels. For example, nifedipine, a calcium channel blocker, reduces calcium-induced desensitization of TRPM channels, indirectly enhancing their activity. Similarly, TBCA inhibits the CK2 pathway, indirectly enhancing TRPM channel activity by reducing CK2-mediated inhibition. Lastly, compounds such as rapamycin and dexamethasone modulate other pathways that indirectly influence TRPM channel activity. Rapamycin, an inhibitor of mTOR, enhances TRPM channel activity by reducing mTOR-mediated inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $28.00 $35.00 $48.00 $125.00 | 2 | |
TRPM6 is a vital magnesium transporter. Magnesium ions can activate TRPM6 by binding to the ion channel, enhancing its transport function. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can bind to TRPM6, enhancing its ion channel activity and thus the flow of magnesium ions. | ||||||
1-O-Oleyl-rac-glycerol | 111-03-5 | sc-201999 | 1 g | $301.00 | ||
This lipid compound can activate TRPM6 by interacting with its lipid-interaction domains, enhancing its magnesium transport function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate the PKC pathway, which can phosphorylate TRPM6 and enhance its activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to an increase in cAMP levels and the subsequent activation of PKA. PKA can phosphorylate TRPM6, stimulating its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterase, causing an increase in cAMP levels. This can activate PKA, which can phosphorylate and enhance TRPM6 activity. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can bind to TRPM6, leading to the enhancement of its ion channel activity and magnesium transport function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, can indirectly enhance TRPM6 activity by reducing calcium-induced desensitization. | ||||||
α,α,α′,α′-Tetramethyl-5-bromomethyl-1,3-benzenediacetonitrile | 120511-84-4 | sc-213217 | 100 mg | $320.00 | ||
TBCA can inhibit the CK2 pathway. CK2 is known to inhibit TRPM6, so blocking CK2 can indirectly enhance TRPM6 activity. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB can modulate TRPM6 activity by binding to the ion channel, enhancing its magnesium transport function. | ||||||